Form 4 for GILD Gilead Sciences
Accepted 2025-03-12 00:00:00 ET · period of report 2025-03-10 · accession 0001127602-25-009265 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-03-12 | 2025-03-10 | GILD | Patterson Sandra | SVP, Controllership | F - Tax | $117.21 | -624 | 39.5K | -2% | -$73.1K |
| D | 2025-03-12 | 2025-03-10 | GILD | Patterson Sandra | SVP, Controllership | M - OptEx | — | +1,952 | 40.1K | +5% | — |
| D | 2025-03-12 | 2025-03-10 | GILD | Patterson Sandra | SVP, Controllership | M - OptEx | — | -1,952 | 9,875 | -17% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-10 | F | D | 624 | $117.21 | 39,453 | D | — | — | (F2) Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-03-10 | M | A | 1,952 | — | 40,077 | D | — | — | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. |
| 3 | Derivative | Restricted Stock Unit | 2025-03-10 | M | D | 1,952 | — | 9,875 | D | — · — to — | 1,952 Common Stock | (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested. |